New Products Shake Up Overlooked Bipolar Disorder Market

 
• By Ayisha Sharma

The highly genericized bipolar disorder market is set for change as both new long-acting injectable formulations of older products and novel therapies reach the market, while firms like NRx and BioXcel target major unmet needs in a disease that needs more R&D.    

• Source: Alamy

More from Market Snapshot

More from Scrip